2422. Efficacy of Cefoxitin for the Treatment of Urinary Tract Infection (UTI) Due to ESBL-Producing E. coli and K. pneumoniae Isolates

BACKGROUND: Cefoxitin has a good in vitro activity and stability in resistance to hydrolysis by ESBLs, and is a good candidate for the treatment of urinary tract infection (UTI). However, data are scarce regarding its use in clinical practice, especially against K. pneumoniae deemed to be capable of...

Descripción completa

Detalles Bibliográficos
Autores principales: Senard, Olivia, Bouchand, Frederique, Deconinck, Laurene, Matt, Morgan, Fellous, Lesly, Rottman, Martin, Perronne, Christian, Dinh, Aurelien, Davido, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253686/
http://dx.doi.org/10.1093/ofid/ofy210.2075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253686/
http://dx.doi.org/10.1093/ofid/ofy210.2075

Ejemplares similares